- Report
- January 2020
- 243 Pages
Global
From €5160EUR$5,370USD£4,429GBP
- Report
- April 2023
- 160 Pages
Global
From €5764EUR$5,999USD£4,948GBP
- Report
- May 2023
- 160 Pages
Global
From €5764EUR$5,999USD£4,948GBP
Ciclosporin is an immunosuppressant drug used to treat a variety of immune disorders, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by suppressing the body's immune system, which helps to reduce inflammation and prevent organ rejection in transplant patients. It is also used to treat certain types of eye inflammation. Ciclosporin is available in both oral and topical formulations.
Ciclosporin is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as high blood pressure, kidney damage, and increased risk of infection.
The ciclosporin market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Novartis, Pfizer, Merck, and Sanofi. Other companies include Mylan, Teva, and Sandoz. Show Less Read more